Bosentas (125 mg) is the first of a new drug class, an endothelin receptor antagonist. Tracleer® is indicated for the treatment of pulmonary arterial hypertension in patients with who class iii or iv symptoms, to improve exercise ability and decrease the rate of clinical worsening . Active ingredients: bosentan